Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2011

01.02.2011 | Materno-fetal Medicine

Calprotectin, RAGE and TNF-α in hypertensive disorders in pregnancy: expression and significance

verfasst von: Chong Feng, Yongjian Tao, Tao Shang, Miao Yu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the expression of calprotectin, the receptor of advanced glycation end products (RAGE) and tumor necrosis factor-α (TNF-α) in hypertensive disorders in pregnancy as well as the significance of their expression.

Methods

The research assessed levels of plasma calprotectin and TNF-α using the enzyme-linked immunosorbent assay, and expression of calprotectin, RAGE and TNF-α in placenta tissues using the immunohistochemistry streptavidin–peroxidase (S–P) method in 60 women with hypertensive disorders in pregnancy and 32 women with normal pregnancy (as the controls).

Results

Compared with the control group, the levels of calprotectin, RAGE and TNF-α were elevated in plasma or placenta tissues in the group with hypertensive disorders in pregnancy, and were positively correlated with severity of hypertensive disorders in pregnancy. The levels of calprotectin were consistent with TNF-α in plasma and placenta tissues in the group with hypertensive disorders in pregnancy.

Conclusion

Changes in calprotectin, RAGE and TNF-α levels in maternal serum and placental tissue correlate to the pathogenesis and disease progression of hypertensive disorders in pregnancy.
Literatur
1.
Zurück zum Zitat Corrêa RR, Gilio DB, Cavellani CL et al (2008) Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 277(3):201–206CrossRefPubMed Corrêa RR, Gilio DB, Cavellani CL et al (2008) Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 277(3):201–206CrossRefPubMed
2.
Zurück zum Zitat Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 50(3):113–123CrossRefPubMed Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 50(3):113–123CrossRefPubMed
3.
Zurück zum Zitat Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29(10):2035–2043CrossRefPubMed Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29(10):2035–2043CrossRefPubMed
4.
Zurück zum Zitat Apel-Sarid L, Levy A, Holcberg G, Sheiner E (2009) Placental pathologies associated with intra-uterine fetal growth restriction complicated with and without oligohydramnios. Arch Gynecol Obstet 280(4):549–552CrossRefPubMed Apel-Sarid L, Levy A, Holcberg G, Sheiner E (2009) Placental pathologies associated with intra-uterine fetal growth restriction complicated with and without oligohydramnios. Arch Gynecol Obstet 280(4):549–552CrossRefPubMed
5.
Zurück zum Zitat Feinshtein V, Ben-Zvi Z, Sheiner E, Amash A, Sheizaf B, Holcberg G (2009) Progesterone levels in cesarean and normal delivered term placentas. Arch Gynecol Obstet Feinshtein V, Ben-Zvi Z, Sheiner E, Amash A, Sheizaf B, Holcberg G (2009) Progesterone levels in cesarean and normal delivered term placentas. Arch Gynecol Obstet
6.
Zurück zum Zitat Polachek H, Holcberg G, Polachek J, Rubin M, Feinshtein V, Sheiner E, Ben-Zvi Z (2009) Carrier-mediated uptake of levofloxacin by BeWo cells, a human trophoblast cell line. Arch Gynecol Obstet Polachek H, Holcberg G, Polachek J, Rubin M, Feinshtein V, Sheiner E, Ben-Zvi Z (2009) Carrier-mediated uptake of levofloxacin by BeWo cells, a human trophoblast cell line. Arch Gynecol Obstet
7.
Zurück zum Zitat Roberts JM, Lain KY (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta 23(5):359–372CrossRefPubMed Roberts JM, Lain KY (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta 23(5):359–372CrossRefPubMed
8.
Zurück zum Zitat Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171(1):158–164PubMed Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171(1):158–164PubMed
9.
Zurück zum Zitat Sharma A, Satyam A, Sharma JB (2007) Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58(1):21–30CrossRefPubMed Sharma A, Satyam A, Sharma JB (2007) Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58(1):21–30CrossRefPubMed
10.
Zurück zum Zitat Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25(1):21–39CrossRefPubMed Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25(1):21–39CrossRefPubMed
11.
Zurück zum Zitat Romero R, Espinoza J, Mazor M (2004) Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril 82(4):799–804CrossRefPubMed Romero R, Espinoza J, Mazor M (2004) Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril 82(4):799–804CrossRefPubMed
12.
Zurück zum Zitat Hsu CD, Witter FR (1995) Urogenital infection in preeclampsia. Int J Gynaecol Obstet 49(3):271–275CrossRefPubMed Hsu CD, Witter FR (1995) Urogenital infection in preeclampsia. Int J Gynaecol Obstet 49(3):271–275CrossRefPubMed
13.
Zurück zum Zitat Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, Ozgoz M, Demir T, Dilsiz A, Yagiz H (2004) Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust NZ J Obstet Gynaecol 44(6):568–573CrossRef Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, Ozgoz M, Demir T, Dilsiz A, Yagiz H (2004) Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust NZ J Obstet Gynaecol 44(6):568–573CrossRef
14.
Zurück zum Zitat Herrera JA, Chaudhuri G, López-Jaramillo P (2001) Is infection a major risk factor for preeclampsia? Med Hypotheses 57(3):393–397CrossRefPubMed Herrera JA, Chaudhuri G, López-Jaramillo P (2001) Is infection a major risk factor for preeclampsia? Med Hypotheses 57(3):393–397CrossRefPubMed
15.
Zurück zum Zitat Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180(2):499–506CrossRefPubMed Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180(2):499–506CrossRefPubMed
16.
Zurück zum Zitat Passey RJ, Xu K, Hume DA, Geczy CL (1999) S100A8: emerging functions and regulation. J Leukoc Biol 66(4):549–556PubMed Passey RJ, Xu K, Hume DA, Geczy CL (1999) S100A8: emerging functions and regulation. J Leukoc Biol 66(4):549–556PubMed
17.
Zurück zum Zitat Kerkhoff C, Klempt M, Sorg C (1998) Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448(2):200–211CrossRefPubMed Kerkhoff C, Klempt M, Sorg C (1998) Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448(2):200–211CrossRefPubMed
18.
Zurück zum Zitat Yui S, Nakatani Y, Mikami M (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753–760CrossRefPubMed Yui S, Nakatani Y, Mikami M (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753–760CrossRefPubMed
19.
Zurück zum Zitat Stríz I, Trebichavský I (2004) Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53(3):245–253PubMed Stríz I, Trebichavský I (2004) Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53(3):245–253PubMed
20.
Zurück zum Zitat Hung TH, Charnock-Jones DS, Skepper JN et al (2004) Secretion Of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164(3):1049–1061PubMed Hung TH, Charnock-Jones DS, Skepper JN et al (2004) Secretion Of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164(3):1049–1061PubMed
21.
Zurück zum Zitat Nakagami H, Cui TX, Iwai M, Shiuchi T, Takeda-Matsubara Y, Wu L, Horiuchi M (2002) Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler Thromb Vasc Biol 22(2):238–242CrossRefPubMed Nakagami H, Cui TX, Iwai M, Shiuchi T, Takeda-Matsubara Y, Wu L, Horiuchi M (2002) Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler Thromb Vasc Biol 22(2):238–242CrossRefPubMed
22.
Zurück zum Zitat Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102(1):20–25CrossRefPubMed Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102(1):20–25CrossRefPubMed
23.
Zurück zum Zitat Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8):1143–1152PubMed Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8):1143–1152PubMed
24.
Zurück zum Zitat Laivuori H, Kaaja R, Koistinen H et al (2000) Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 49(2):259–263CrossRefPubMed Laivuori H, Kaaja R, Koistinen H et al (2000) Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 49(2):259–263CrossRefPubMed
25.
Zurück zum Zitat Knackstedt M, Ding JW, Arck PC et al (2001) Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 46(3):196–210CrossRefPubMed Knackstedt M, Ding JW, Arck PC et al (2001) Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 46(3):196–210CrossRefPubMed
26.
Zurück zum Zitat Larsson PT, Hallerstam S, Rosfors S et al (2005) Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol 24(1):43–51PubMed Larsson PT, Hallerstam S, Rosfors S et al (2005) Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol 24(1):43–51PubMed
27.
Zurück zum Zitat Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427–1435PubMed Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427–1435PubMed
Metadaten
Titel
Calprotectin, RAGE and TNF-α in hypertensive disorders in pregnancy: expression and significance
verfasst von
Chong Feng
Yongjian Tao
Tao Shang
Miao Yu
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1303-x

Weitere Artikel der Ausgabe 2/2011

Archives of Gynecology and Obstetrics 2/2011 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.